Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Chang Sik Lee
A Novel Histone Deacetylase Inhibitor, CKD5, Has Potent Anti-Cancer Effects in Glioblastoma
Oncotarget
Oncology
Combustion and Emission Reduction Characteristics of GTL-Biodiesel Fuel in a Single-Cylinder Diesel Engine
Energies
Control
Electronic Engineering
Energy Engineering
Renewable Energy
Energy
Fuel Technology
Sustainability
Optimization
Electrical
Power Technology
the Environment
Related publications
Preclinical Anti-Arthritic Study and Pharmacokinetic Properties of a Potent Histone Deacetylase Inhibitor MPT0G009
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Santacruzamate A, a Potent and Selective Histone Deacetylase Inhibitor From the Panamanian Marine Cyanobacterium cf.Symplocasp.
Journal of Natural Products
Organic Chemistry
Molecular Medicine
Pharmacology
Complementary
Pharmaceutical Science
Analytical Chemistry
Alternative Medicine
Drug Discovery
A Chimeric SERM-Histone Deacetylase Inhibitor Approach to Breast Cancer Therapy
ChemMedChem
Organic Chemistry
Molecular Medicine
Pharmacology
Biochemistry
Toxicology
Drug Discovery
Pharmaceutics
Activity of PXD101, a Histone Deacetylase Inhibitor, in Preclinical Ovarian Cancer Studies
Molecular Cancer Therapeutics
Cancer Research
Oncology
Givinostat, a Type II Histone Deacetylase Inhibitor, Induces Potent Caspase-Dependent Apoptosis in Human Lymphoblastic Leukemia
Genes and Cancer
Cancer Research
Genetics
Mechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer Cells
Antioxidants and Redox Signaling
Cell Biology
Molecular Biology
Biochemistry
Clinical Biochemistry
Medicine
Physiology
Selective Inhibition of IL-Gene Expression by 2Trichostatin A, a Potent Inhibitor of Mammalian Histone Deacetylase.
Journal of Antibiotics
Drug Discovery
Pharmacology
Discovery of N-(2-Aminophenyl)-4-(Bis(2-Chloroethyl)amino)Benzamide as a Potent Histone Deacetylase Inhibitor
Frontiers in Pharmacology
Pharmacology
Preclinical Validation of AR42, a Novel Histone Deacetylase Inhibitor, as Treatment for Vestibular Schwannomas
Laryngoscope
Otorhinolaryngology
